Raymond James & Associates Optimize Rx Corp Transaction History

Raymond James & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$21.94 - $40.49 $12,088 - $22,309	-551 Reduced 4.55%	11,565 $317,000
Q1 2022 May 11, 2022	BUY	$35.27 - $62.91 $74,454 - $132,803	2,111 Added 21.1%	12,116 $457,000
Q4 2021 Feb 08, 2022	BUY	$53.57 - $98.0 $27,213 - $49,784	508 Added 5.35%	10,005 $621,000
Q3 2021 Nov 02, 2021	SELL	$50.93 - $85.55 $180,292 - $302,847	-3,540 Reduced 27.15%	9,497 $812,000
Q2 2021 Aug 11, 2021	SELL	$42.76 - $63.33 $3,078 - $4,559	-72 Reduced 0.55%	13,037 $807,000
Q1 2021 May 14, 2021	BUY	$33.36 - $62.2 $102,915 - $191,887	3,085 Added 30.78%	13,109 $639,000
Q4 2020 Feb 12, 2021	SELL	$19.04 - $33.1 $14,089 - $24,494	-740 Reduced 6.87%	10,024 $312,000
Q3 2020 Nov 04, 2020	BUY	$12.99 - $21.78 $139,824 - $234,439	10,764 New	10,764 $224,000

13.3M

79.8K

41.4K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $140M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.